Quarterly report · Q2

Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥484m2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥1.8bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.3bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income−¥96m2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥111m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income−¥124m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥268m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥238m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax−¥112m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥291m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥99m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥348m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥249m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income−¥99m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥251m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥8.5bnat 2023-09-30Cons.Assets
Total assets¥8.4bnat 2023-03-31Cons.Assets
Total assets¥8.4bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥594mat 2023-09-30Cons.Liabilities
Total liabilities¥426mat 2023-03-31Cons.Liabilities
Net assets / equity¥7.9bnat 2023-09-30Cons.Net assets
Net assets / equity¥8.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥7.9bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.9bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥3.0bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥2.9bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.6bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.8bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow−¥44m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥755m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥409m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥65m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥769m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥777m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥45m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥364m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥362m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-10.992023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.832023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.472022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.592022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.72022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio90.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio93.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio92.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥192m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥418m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥418m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥75m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥66m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥66m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥20m
—segment totalrevenue2023-04-01 → 2023-09-30¥484m
—segment totalrevenue external2023-04-01 → 2023-09-30¥484m
—segment totalsegment profit2023-04-01 → 2023-09-30¥95m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥484m
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥484m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥95m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥241m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥623m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥623m
jpcrp040300-q2r_E04034-000Medical Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥258m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥643m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥643m
jpcrp040300-q2r_E04034-000Real Estate Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥94m
—segment totalrevenue2022-04-01 → 2022-09-30¥1.3bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥1.3bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥353m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥353m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 530
ItemContextValueUnit
Provision for bonuses sgaPrior1YTDDuration43000000JPY
Provision for bonuses sgaCurrentYTDDuration-13000000JPY
Share based compensation expenses sgaPrior1YTDDuration55000000JPY
Share based compensation expenses sgaCurrentYTDDuration19000000JPY
Retirement benefit expenses sgaPrior1YTDDuration1000000JPY
Retirement benefit expenses sgaCurrentYTDDuration2000000JPY
Welfare expenses sgaPrior1YTDDuration45000000JPY
Welfare expenses sgaCurrentYTDDuration32000000JPY
Rent expenses sgaPrior1YTDDuration30000000JPY
Rent expenses sgaCurrentYTDDuration29000000JPY
Depreciation sgaPrior1YTDDuration8000000JPY
Depreciation sgaCurrentYTDDuration6000000JPY
Compensations sgaPrior1YTDDuration31000000JPY
Compensations sgaCurrentYTDDuration26000000JPY
Commission fee sgaPrior1YTDDuration91000000JPY
Commission fee sgaCurrentYTDDuration29000000JPY
Subcontract expenses sgaPrior1YTDDuration12000000JPY
Subcontract expenses sgaCurrentYTDDuration4000000JPY
Other selling expenses sgaPrior1YTDDuration98000000JPY
Other selling expenses sgaCurrentYTDDuration66000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember623000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember643000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember1267000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1267000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersPrior1YTDDuration1267000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember-JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember-JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-JPY
Transactions with other segmentsPrior1YTDDuration-JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember623000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember643000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember1267000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1267000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-JPY
Net salesPrior1YTDDuration1267000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember258000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember94000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember353000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember353000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-241000000JPY
Operating incomePrior1YTDDuration111000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E04034-000MedicalBusinessReportableSegmentsMember418000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E04034-000RealEstateBusinessReportableSegmentsMember66000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember484000000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember484000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember-JPY
Revenues from external customersCurrentYTDDuration484000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass